Assessment of Osteoprotegerin and Receptor Activator of Nf-Κb Ligand in Malaysian Male Patients with Chronic Obstructive Pulmonary Disease : A Cross-Sectional Study

• المؤلفون الرئيسيون: Ahmad N., Bitar, Majed Ahmed, Al-Mansoub, Syed A., Syed-Sulaiman, Fadi G., Saqallah, Irfhan A.B, Hyder-Ali, Salah A., Alshehade, Amer, Hayat-Khan
• التنسيق: مقال
• اللغة: English
• منشور في: Permanyer 2024
• الموضوعات: RM Therapeutics. Pharmacology
• الوصول للمادة أونلاين: http://ir.unimas.my/id/eprint/47026/1/Assessment%20of%20Osteoprotegerin.pdf; http://ir.unimas.my/id/eprint/47026/; https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=517

Background: Limited information exists regarding the pathophysiological interactions between osteoporosis and chronic obstructive pulmonary disease (COPD). Objective: To study the association of Osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-Β ligand (RANKL) in male COPD patie...